Catalyst Wire Dossier Catalyst Wire Dossier

Belcesiran

belcesiran · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Belcesiran, covering 2024-09-19 to 2024-12-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Belcesiran in Patients With AATLD [Phase 2]

See pricing